CORPORATE

PRESENTATION

DECEMBER2018

OTCQX:BLEVF

CNSX:BE

ALeadingGlobalCannabisCompany

OurVision:

Beleavewillcontinuetobealeading,global,

vertically-integratedcannabiscompany.

Wecultivatehigh-qualitycannabis

flowerandextracts,andaredeveloping

additionalproductlinesfor2019.

Withafootprintin

Canada,SouthAmerica,andEurope,

andfundedcapacityofover150,000kg

peryear,wearewellonourway.

2December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

3

ProductDevelopment

BuiltonResearch

DedicatedR&DTeam

focusedondevelopingproductsto

capitalizeonconcentratesand

edibleswhenallowedin2019

Proprietaryextraction

andprocessingtechniques

(patentpending)

Collaborationwith

academicinstitutions

Production

Capacity

Overallproduction

capacityinexcess

of150,000kg/yr

Overallfootprint

totalling1,642,000sqft

ofindoorandgreenhouse

Industryleadingyields

Facilitiesstrategicallylocated

acrossCanadaandabroad

Retail

Expansion

Retailchannelproviding

province-wideaccessto

Saskatchewanmarket

Pre-qualifiedbytheManitoba

governmentforretail

locationsinManitoba

Capabilitytoofferretailat

flagshipfacilityin

London,Ontariowithfurther

franchiseopportunities

beingexplored

Salesand

Distribution

Currentprovincialsupply

agreementswithaccessto

over55%ofthe

Canadianpopulation

Strategytocapitalizeon

internationalopportunities

withagreementstosupply

SouthAmericanand

Europeanmarkets

Diversifiedbrands,

abletoservelargeand

nichemarketsalike

OTCQX:BLEVF

CNSX:BE

WhoWeAre

December2018

BeleaveInc.

www.beleave.com

4December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

April13

BeleaveReceivesSales

LicensefromHealth

Canada

May10

BeleaveCloses

AcquisitionofMedi-

GreenCannabisClinic

Network

June21

BeleaveExpandsits

GlobalFootprint

intoColombia

July19

BeleaveAccelerates

itsRecreational

DistributionStrategy

byAcquiring

SevenOaks

August7

BeleaveExpands

Medi-Green

Networkwiththe

Announcementof

TwoNewStores

September6

BeleaveSigns

AgreementtoAcquire

250,000SquareFeetof

GreenhouseSpaceand

85AcresofLandto

ExpanditsProduction

Capabilities

September20

BeleaveAnnounces

867,000SquareFeet

ofPlannedIndoor

GrowingCapacityin

BritishColumbia

September26

BeleaveAnnounces

IncreasedInvestment

Agreementforup

to$30millionwith

AluminaPartners

August30

BeleaveSecures

PrimeLocation

foritsFirst

Saskatchewan

RetailStore

October17

RecreationalCannabis

isLegalizedinCanada

October29

BeleaveExpands

intoEuropean

CannabisMarket

Summer/Fall2019

London,Ontario

Facilitycomes

onlinewith250,000

squarefeetof

indoorgrowspace

Summer/Fall2019

Thefirsttwooften

newBCfacilitiesare

completed,adding

173,400squarefeet

togrowingcapacity

Summer/Fall2019

Recreationalmarket

expandsascommercially

manufacturededibles,

beverages,andconcentrates

arelegalized

2018

andBeyond

November15

BeleaveAnnounces

Developmentof

Cannabis-Infused

PowderandSugar

Productsforthe

RecreationalMarket

5December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

IntheNews

March25,2017

“Hamiltonishometoatleastthreemajor

marijuanacultivators,amongthe40growers

licensedbythefederalgovernmenttogrowpot

formedicinalpurposes.”

May10,2017

“Marijuanastartupsgetnew

fundingfrom'streaming'deals.”

June30,2017

“Withayeartogoandamidpredictionsofalooming

supplyshortage,HealthCanadaisscramblingtoadd

capacityoncethelegalizationfloodgatesswingopen.”

August23,2018

“Growthonthehorizonforlicensedpotproducers.”

BeleaveintheNews

Whetherit’sastoryon

cannabisemployersand

entrepreneurs,oralive

interviewthemorning

recreationalcannabis

becamelegalinCanada,

Beleavehashadgreat

newsworthymoments.

August29,2018

“B.C.governmenthasbeguntobuybud.”

August31,2018

“Areyouexperienced?Lloydminster

marijuanaretailerlookingfor'qualified'

workers.”

September12,2018

“ToutingLondon'sproximitytohighwaysanditslarge

labourpool,apotproducerhasboughtupagreenhouse

onasprawlingpropertyinthecity'ssouthend.”

October17,2018

BeleaveinvitesCP24camerasintotheir

Hamiltonfacilityforatourandlearn

moreabouttheiroperationsthemorning

ofCanadiancannabislegalization.

November9,2018

“FollowtheMoneyInvestorsGroupinterviewsBojan

Krasic,President&CFOofBeleaveInc.

Hamilton,OntarioThefirstpropertyintheBeleave

portfolio,theHamiltonfacility

continuestobethehubofoperations

forextraction,packaging,and

distribution.

GMPCertification:

ExpectedinDecember2018

ISOCertification:

Anticipatedinearly2019

Certificationwillfacilitate

internationaldistribution

London,OntarioExistinggreenhousetoberetrofitted

with160,000sqftofspaceonan

85acreproperty.

Phase1

StartingSummer2019

Indoor:10,000sqft

Phase2

StartingFall2019

Greenhouse:150,000sqft

Phase3

StartingSummer2020

Outdoor:600,000sqft

TotalLondonCapacityIndoor:8,697kg/yr

Greenhouse:18,000kg/yr

Outdoor:18,000kg/yr

BritishColumbiaTenindoorgrowingfacilitiesjointly-

designedbyBeleaveandKannavis

BiotechCorp.,ona50/50operating

expenditureandrevenuepartnership.

Phase1

StartingFall2019

Indoor:Abbotsford86,700sqft

Indoor:Chilliwack86,700sqft

Phase2

StartingFall2020

Indoor:Abbotsford700,800sqft

TotalBCCapacity

Indoor:65,232kg/yr

6December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

Facilities:

ExpansionPhases

GREENHOUSE

OUTDOOR

INDOOR

7

Hamilton

London

London

BritishColumbia

876,000

SQFT

600,000

SQFT

160,000SQFT

6,000

SQFT

2020TOTAL

160,000sqft

600,000sqft

882,000sqft

December2018

BeleaveInc.

www.beleave.com

OpenNow

StartingSummer2019

StartingSummer2020

StartingFall2019

1,642,000sqft

OTCQX:BLEVF

CNSX:BE

FundedCapacity:

Breakdown

8December 2018Beleave Inc.www.beleave.com

Funded Capacity (kg/yr) as at November 29, 2018

OTCQX: BLEVFCNSX: BE

Funded Capacity:Industry Comparison

0KG

150,000KG

300,000KG

450,000KG

600,000KG

WEED ACB APH TGOD BE CRON OGI TRST FIRE HIP FLWR TER

Year

ly F

unde

d Ca

pacit

y

9December2018

BeleaveInc.

www.beleave.com

CompanyTotalFunded

Capacity(kg)

MarketCap

(inmillions)

TotalFunded

Footprint(sqft)

Oils/

Extraction

Company

Clinics

CompanyRetail

Stores

University/

Research

International

OperationsRevenues

AuroraCannabis 570,000 8,980 4,505,000 Yes No Yes Yes Yes Yes

CanopyGrowth ~540,000 11,950 5,600,000 Yes No Yes Yes Yes Yes

Aphria 225,000 4,130 - Yes No No No Yes Yes

TGOD 170,000 1,100 1,257,245 Yes No No No Yes No

Beleave 150,000 86 1,642,000 Yes Yes Yes Yes Yes Yes

CronosGroup 117,150 2,020 1,201,000 Yes Yes No Yes Yes Yes

OrganiGram 110,000 776 480,000 Yes Yes No No Yes Yes

CannTrust 100,000 914 1,110,000 Yes No No Yes Yes Yes

Supreme 50,000 520 342,000 No No No No Yes Yes

FSDPharma - 611 ~3,800,000 No No No Yes Yes No

Newstrike 25,000 278 320,000 No No Yes No No Yes

Flowr 12,000 337 85,000 No No No Yes No No

TerrAscend ~2000 805 ~18,000 Yes Yes No No No Yes

AsatNovember9,2018

OTCQX:BLEVF

CNSX:BE

Peer

Comparison

10

$1,440,000240,000g

$14,486,4002,414,400g

$67,352,40012,350,400g

2019Total Revenues: $118,015,200Total Grams: 21,919,200

2020Total Revenues: $397,584,400Total Grams: 78,273,600

$34,736,4006,914,400g

$1,440,000240,000g

$1,440,000240,000g

$67,352,40012,350,400g

$130,352,40030,350,400g

$67,352,40012,350,400g

$132,584,40023,222,400g

Attributable to Beleave bottom line

0

5

10

15

20

25

30

35

0

20

40

60

80

100

120

Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3 2020 Q4 2020

Gram

s

Mill

ions

Reve

nue

/ Pr

oduc

t Val

ue

Mill

ions

* Based on current average wholesale price of $5.33** Revenues and yields are net of JV deductions

Revenue

Grams

RevenueForecast

December 2018Beleave Inc.www.beleave.com

OTCQX: BLEVFCNSX: BE

SalesandDistribution:

Canada

11

PlannedRetailLocation

RecreationalOnlineSales

MedicalDistribution

December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

Now

Countrywide

100%ofCanada

RecreationalDistribution

Now

BC,MB,ON

55.1%ofCanada

Spring2019

+AB,SK

69.8%ofCanada

Summer2019

+ QB,NS,NB

97.5%ofCanada

2020

+ YT,NT,NU,NL

99.59%ofCanada

TodayBeleavehasaccesstooverhalfoftheCanadianrecreational

marketplace;thatnumberwillsoartoover97%bySummer2019.

Provincialpopulationpercentagesbasedon2016CanadianCensus

12OTCQX:BLEVF

CNSX:BE

SalesandDistribution:

SouthAmerica

December2018

BeleaveInc.

www.beleave.com

SouthAmericanExpansion

InJune2018,Beleaveexpanded

itsglobalfootprintintoSouth

Americabyacquiringamajority

shareinProcannmed;fully

licensedforthecultivation,

production,extractionand

distributionofbothTHCandCBD

medicalcannabisinColombia.

• DistribuhonthroughoutColombia

andotherSouthAmericanmarkets

• 60Hectaresoflandcanbeusedfor

outdoorgrowingordevelopmentof

newgrowingfacilihes

• Lowcostoffacilityconstruchonand

operahonskeepexpenseslow

• Asregulahonsformedicalcannabis

changeintheregion,themarketof

620millionpeoplewillpresentnew

growthopportunihesforBeleave

13OTCQX:BLEVF

CNSX:BE

SalesandDistribution:

Europe

December2018

BeleaveInc.

www.beleave.com

EuropeanExpansion

InOctober2018,Beleave

expandeditsglobalfootprint

again,thistimetoEurope,by

partneringwithCanymedto

supplytheGermanmarketwith

medicalcannabis.

• Canymedtoimport5,000kgdryflower

peryearfromBeleaveat€7.00/g

• Beleavewillreceive10%ownershipin

Canymedandfirstrightofrefusalfor

anaddihonal20%inexchangefor

providingexperhse,training,

consultahonandsupport

• Germanyhasquicklybecomeoneof

theworld'slargestfederally-regulated

medicalcannabismarket

14December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

MarketOverview

GrowingMarketConservativeestimatesfromHealth

Canadapredictthatthesizeofthe

medicalcannabismarketwillreach

450,000patientsinthenextsixyears.

ExportOpportunitiesNewopportunitiesareonthehorizon

forCanadianLPstosupplyforeign

medicalmarketsasmanySouth

AmericanandEuropeannationslack

domesticproductioncapacity.

IndustryGrowthRecreationalmarketinCanadaisexpected

requirecannabisproductionofover

900,000kgannuallytomeetitsestimated

valueof$8.7billioninthenextsixyears.

RetailDistributionManyprovinceswillsoonbe,oralreadyare,

intheprocessofacceptingapplicationsfor

morepoint-of-salelocations,andretail

distributionpointsareexpectedtogrow

substantiallyin2019.

ImpactfulResearchImpactfulstudieshighlightthepromise

ofcannabistoaidinhealthyaging,

neurologicalanddegenerativediseases,

andasapowerfulweaponagainstthe

opioidcrisis.

NewProductLinesCompaniesarecommittingR&Dresources

todevelopawidevarietyofnewproduct

offeringsastherecreationalmarketwillallow

foredibles,concentrates,andbeverage-

basedcannabisproductsin2019.

MedicalMarket RecreationalMarket

2019

SevenOaks

SevenOaks,BeleaveInc.’srecreational

brand,hasstrongdistributionandsales

channelsinplace.SevenOaksappeals

toconsumers,bothconceptuallyandin

thequalityitinvokes,attractingthemto

becomerepeatcustomers.

BeleaveKannabis

BeleaveKannabis,ourmedicallabel,is

distributednation-wide.In2019,weare

leveragingresearchandnew

technologiestocreateasuiteofhighly

focused,proprietarymedicalproducts,

withhighermargins.

Medi-Green

Medi-Greenisaleadingnetworkof

medicalcannabisclinicswithlocations

acrossOntarioandQuebec.Medi-Green

currentlyhasanactivepatientbaseof

approximately4,000,withaverage

patientsubscriptionsintherangeof

2to3gramsperday.

RapidlyAcceleratingbothRecreationalandMedicinalDistribution

Ourlong-termobjectiveisclear;weprovideaconsistent,reliableandcuratedproducttosuitthe

needsofourcustomers.Oursuiteoftargetedbrandsenablesustobuildloyaltyandenthusiasm

acrosstheBeleavefamily.

COMINGSOONIN2019

FirstrecreationalstorewillopeninSaskatchewaninthecomingmonths,allowingforprovince-wideonlinesales.Also,Beleavehaspre-qualifiedfor

storesinManitobaandwillopenanumberlocationsinOntariothroughitspartnershipwithRollinsGroup.

15OTCQX:BLEVF

CNSX:BE

SalesandDistribution:

OurBrands

December2018

BeleaveInc.

www.beleave.com

x

SalesandDistribution:

OurProducts

16December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

CBDGodBud

Gellatino

Shishkaberry

UltraSour

PinkKush

SanFernandoValleyKush

BlueDream

CannabisStrainsProductPackaging

BELEAVEKANNABIS

SEVENOAKS

Formedbynature,

perfectedbyscience.

Solving

Bio-Availability

Weusenano-encapsulationofactive

ingredientstoenhancebioavailability.

Thefinalproductofferedto

consumerswillbeaflexible,food-

gradeingredientthatdeliversan

accuratedoseofTHCandCBDwhen

ingestedorally,withspeedydelivery.

Patenting

Solubility

Lowwatersolubilityofextractsoroils

makesincorporatingthemintofood

productsorbeveragesdifficultand

canleadtolowbioavailability,poor

shelf-life,andunpredictabledosing;

ourpatent-pendingprocess

addressesandsolvestheseproblems.

Patenting

Extraction

R&DbeingconductedatBeleave's

Hamiltonfacilitystemsfromapatent

applicationsubmittedbyDr.Chenand

Dr.Rogers,andisownedbyBeleave.

Manufacturingandextractionwillbe

scaled-uptoindustriallevelsand

movedtoBeleave'sLondon,Ontario

facilityinthefuture.

OnNovember15,2018,Beleaveannouncedithaddeveloped

water-solublecannabis-infusedpowdersandsugarproducts

inpreparationfortheadultrecreationalcannabis-infused

foodandbeveragemarketnextyear.

17OTCQX:BLEVF

CNSX:BE

Product

Development

December2018

BeleaveInc.

www.beleave.com

18OTCQX:BLEVF

CNSX:BE

RiskMitigation

December2018

BeleaveInc.

www.beleave.com

TightProductControlsConsistentproductqualityisattained

throughconstantmonitoringand

testingtoensureplantsarefree

fromchemicals,heavymetalsand

microbiologicalcontaminants.

IntegratedDistributionIntegrateddistributionchannelsmake

Beleavestronger,providingdirect

accesstothemarketsweserve.

InternationalExpansionGlobalpoliticalchangestomedicinaland

recreationalcannabislawsallowBeleave

tocapitalizeonmarketsoutsideof

Canada.

BrandDiversityAuthenticbrandofferingsthataretargeted

toclearlydefineddemographicswith

multipleprice-pointstoreachbroad

customerprofilesandbuildbrandloyalty.

Mutuallybeneficialpartnershipsproducegroundbreaking

researchandinnovationthatdriveseconomicgrowth,solves

complexproblems,andcreatesamoreskilledworkforce.

Dr.LesleyCampbellisaProfessorintheDepartmentofChemistryandBiologyatRyersonUniversity.Sheis

anevolutionarybiologistwithastronghistorystudyingweedyandinvasiveplantevolutionandcurrently

possessesafederallyissuedIndustrialHempResearchLicense.ShehaspreviouslyworkedonindustrialC.

sativaproductionproblemsincludingheritability,maternaleffects,phenotypicplasticityandextractionprotocols.

Dr.MohitBhandariisaworld-leadingresearcherspecializinginlargeinternationalResearchChairat

McMasterUniversity,aUniversityScholar,andtheAssociateChairofResearchforSurgery.Hewaswon

numerousawardsforcontributionstoresearchandevidence-basedorthopaedicsincludingtheOrderof

Ontario,andtheKappaDeltaaward.

MichaelRogersjoinedtheDepartmentofFoodSciencein2014afterholdingfacultypositionsatRutgers

UniversityandtheUniversityofSaskatchewanandastheCenterDirectorfortheGastrointestinalPhysiology

CenteratNewJersey’sInstituteofFood,NutritionandHealth.Hestudiesmoleculargels,self-assemblyof

nano-fibersandnanotechnology,focusingondeliveryofbio-activesandthebiophysicsofdigestion.Michaelis

alsothedepartment’sgraduatecoordinatorfortheM.Sc.thesisandPh.D.programs.

LESLEYCAMPBELL,PH.D.

RYERSONUNIVERSITY

MOHITBHANDARI,PH.D.

MCMASTERUNIVERSITY

MICHAELROGERS,MSC&PH.D.

GUELPHUNIVERSITY

InsertLogo

19December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

Collaborative

Partners

MeettheTeam

20December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

AndrewT.Wnek

CA,CPA,B.COMM,MBA

Chairman,ChiefExecutiveOfficer,

Director

Andrew offers significant retail,

f i n a n c e a n d i n f o r m a t i o n

technology experience from

previous execut ive ro les at

Canadian Tire, Petro-Canada, and

Heart and Stroke Foundation. He

has led sizeable organizations and

successfully executed on major

projects.HisvisionforBeleaveisto

be come a f u l l y i n teg ra ted

organization that will have a

significant leadership position in

thecannabisindustry.

BojanKrasic

MIM

President,ChiefFinancialOfficer,

Director

Bojan was responsible for leading

strategy, business development,

M&A transactions for Beleave.

Withwell over a decade of career

development, Bojan offers wide

ranging financial expertise built

with Thomas Weisel Partners

CanadaInc.,StifelNicolausCanada

Inc., and later serving as CEO of

Terrella Capital and is a board

member of public and private

companies.

BillPanagiotakopoulos

ChiefOperationalOfficer,Director

BillwasanearlymoverinCanada’s

cannabissectorandhascontributed

significantly tosuccessfullynavigating

the regulatory framework to

obtain a cannabis production and

sales license. Bill was the founder

and owner of Cardinal Group Inc,

specializinginevaluatingopportunities

and helping set strategic goals in

businessdevelopment.

RogerFerreira,Ph.D.

ChiefScienceOfficer,Director

Roger leads Beleave's science and

innovation program and offers

substantialexperiencein laboratory

management(UniversityofToronto

& Toronto University Health

Network) and his PhD training in

theareaofneuroimmunology.

KevinKeagan

ChiefCommunicationsOfficer

Kevin brings extensive experience,

with over 25 years in capital

marketsworkingwithinthefinancial

services industry to provide

overs ight to the operat ion ,

expans ion, and d i rect ion of

Beleave's communications and

capital markets initiatives. As

Beleave prepares for exciting

announcements in the next year,

Kevinwillprovidevaluablestrategic

guidancetosupporttheourgrowth

anddevelopment.

GrantMcLeod

SVP,RegulatoryAffairs

GeneralCouncil

Grantisalawyerwithover14years

of government and regulatory

experience.Granthasledanumber

of public sector organizations

providing significant organizational

skills and corporate governance

experience to draw on. His past

positionshaveincludedseniorroles

at the Privy Council Office, the

AttorneyGeneral’sOffice (Ontario),

a n d f o r U S g o v e r n m e n t

i m p l em e n t i n g p a r t n e r s i n

Afghanistan. Grant is the Co-

Founder of SevenOaks,whichwas

acquired by Beleave, and was

instrumental in securing provincial

supplyagreements.

MarkHeselton

Director

Markisanexperiencedpharmaceutical

executive offering more than 25

yearswithFortune100,NYSElisted,

research-based pharmaceutical

companies including Bristol-Myers

Squibb,MerckandPfizer.

MarkMiles

Director

Mark is the President of M2PM

Limited and has more than thirty

y e a r s o f e x p e r t i s e i n t h e

construction and development

industries, and tenyearsdedicated

toexecutiveservicesfortheproject

design, construction and delivery

for a full spectrum of publicly

procured infrastructure projects,

including complex construction

projects, including the SkyDome,

Metro Hall, Sunnybrook Hospital

and PrincessMargaret Hospital, to

nameafew.

MeettheTeam

21December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

22December2018

BeleaveInc.

www.beleave.com

ShareStructureasofNovember29,2018 Amount Percentage

CommonSharesOutstanding 419,215,391 81%

ReservedforIssuance*

98,607,047 19%

FullyDilutedShares 517,822,438 100%

CanadianListing-CNSX:BE

USListing-OTCQX:BLEVF

CashBalance

(asatSeptember30,2018)$3,578,996

*Reservedforissuanceincludesstockoptionsandwarrants

OTCQX:BLEVF

CNSX:BE

Capitalization

23December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

Key

Takeaways

• Canadian-basedverhcallyintegrated

cannabiscompany

• Operahonsinthreeconhnents;North

American,SouthAmerica,Europe

• Fundedcapacityover150,000kg

peryear

• Culhvahngcannabisforflower,oils,

andextracts

• Recreahonalsalesin3provinces

currently,expandingto8bymid-2019

• Expandingmedicaldistribuhon

channelsinternahonally

• Industry-leadingyieldswithlow

produchoncosts

• Passionate,experienced,and

industry-connectedleadershipteam

• Developingnewproductsfor2019

AndrewT.WnekCHAIRMAN&CEO

4166691530

ANDREW@BELEAVE.COM

BojanKrasicPRESIDENT&CFO

9059792937

BOJAN@BELEAVE.COM

24December2018

BeleaveInc.

www.beleave.com

OTCQX:BLEVF

CNSX:BE

Contact

KevinKeaganCHIEFCOMMUNICATIONSOFFICER

6474497352

KEVIN@BELEAVE.COM

This document includes forward-looking statementswithin themeaning of certain securities laws, including the “safe harbour” provisions of the

SecuritiesAct(Ontario)andotherprovincialsecurities lawinCanada.Theseforward-lookingstatements include,butarenot limitedto,statements

with respect toourobjectives,goalsandstrategies toachieve thoseobjectivesandgoals,aswellasstatementswith respect toourbeliefs,plans,

objectives,expectations,anticipations,estimatesandintentions.Thewords“may”,“will”,“could”,“should”,“would”,“suspect”,“outlook”,“believe”,

“plan”, “anticipate”, “estimate”, “expect”, “intend”, “forecast”, “objective” and “continue” (or the negative thereof), andwords and expressions of

similar import, are intended to identify forward-looking statements. By their very nature, forward-looking statements involve inherent risks and

uncertainties,bothgeneralandspecific,whichgiverisetothepossibilitythatpredictions,forecasts,projectionsandotherforward-lookingstatements

willnotbeachieved.Certainmaterialfactorsorassumptionsareappliedinmakingforward-lookingstatementsandactualresultsmaydiffermaterially

fromthoseexpressedorimpliedinsuchstatements.TheCompanystronglycautionsreadersnottoplaceunduerelianceonthesestatements,asa

numberofimportantfactors,manyofwhicharebeyondourcontrol,couldcausetheCompany’sactualresultstodiffermateriallyfromthebeliefs,

plans,objectives,expectations,anticipations,estimatesandintentionsexpressedinsuchforward-look-ingstatements.Thesefactorsinclude,butare

notlimitedto:generaleconomicconditions;pendingandproposedlegislativeorregulatorydevelopmentsinCanadaincludingtheimpactofchanges

in laws, regulations and the enforcement thereof; reliance on funding models in Canada; operational and infrastructure risks including possible

equipment failureandperformanceof information technology systems; intensify- ing competition resulting fromestablishedcompetitorsandnew

entrantsinthebusinessesinwhichtheCompanyoperates; insurancecoverageofsufficientscopetosatisfyanyliabilityclaims;fluctuationsintotal

patients and customers; technological change and obsolescence; loss of services of key senior management personnel; privacy laws; structural

subordinationofcommonshares;leverageandrestrictivecovenants;fluctuationsincashtimingandamountofcapitalexpenditures;tax-relatedrisks;

unpredictabilityandvolatilityof thepriceof theCompany’ssecurities;dilution;and futuresalesof theCompany’ssecurities.The foregoing listofimportantfactorsthatmayaffectfutureresultsisnotexhaustive.WhenreviewingtheCompany’sforward-lookingstatements,investorsandothers

should carefully consider the foregoing factors and other uncertainties and potential events. Except as required by Canadian securities law, the

Company does not undertake to update any forward-looking statements, whether written or oral, that may bemade from time to time by the

CompanyorontheCompany’sbehalf.Suchstatementsspeakonlyasofthedatemade.Theforward-lookingstatementscontainedinthisDocument

shouldnotberelieduponasrepresent- ingtheviewoftheCompanyor itsmanagementasofanydatesubsequenttothedateofthisDocument.

NeithertheCompanynoritsmanagementisunderanyobligation,andneitherundertakes,toupdateanyofthisinformationatanyparticulartime.

NeithertheCompanynoritsmanagementassumesanyobligationtoupdateorreviseforwardlookingstatementsshouldcircumstancesorestimates

oropinionschanges.NoneoftheCompanyor itsaffiliatedorrelatedpartnershipsandcorporationsortheirrespectivedirectors,officers,partners,

employees,agentsorrepresentativesmakesanyrepresentationorwarrantyastotheaccuracyorcompletenessoftheDocumentoranystatements,

estimatesorprojections,andnonewillassumeanyliabilityforanyrepresentations(expressorimplied)containedin,orforanyomissionsfrom,the

Document,orforanyotherwrittenororalcommunicationstransmittedtoprospectiveinvestorsinthecourseoftheirevaluationoftheCompanyand

itsbusiness.An investorwillonlybeentitledtorelyonthoserepresentationsandwarrantiescontained inthedefinitiveagreementoragreements

whichconstitutethefinancing.UseofthisDocumentisrestrictedtopartiestowhomtheCompanydeliverstheDocumentandtherecipientandits

representativesshallkeepconfidentialallinformationcontainedhereinorotherwiseprovidedinconnectionwiththeproposedfinancingwhichisnot

alreadypublicorwhichisnotsubsequentlymadepublic,andwillusetheDocumentonlyforthepurposesetforthabove.Inaddition,eachrecipient

willnotcopy,reproduceordistributetheDocumentinwholeorinparttoothers,atanytime,withoutthepriorexpresswrittenconsentoftheCompany.

25OTCQX:BLEVF

CNSX:BE

Disclaimer

December2018

BeleaveInc.

www.beleave.com